Gland Pharma Limited

NSE:GLAND.NS

1703.4 (INR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 28,201.08-18,394.3218,394.32-21,447.344,808.2-37,706.7519,088.95-32,950.345,341.89-32,483.153,158.24-29,284.152,716.37-30,057.54,918.23,817.821,694.97-7,207.47
Short Term Investments 036,788.6417,342.7842,894.6817,281.4575,413.519,273.0165,900.6828,590.5964,966.329,268.9358,568.327,377.1960,11519,546.8511,470.3711,427.2814,414.94
Cash and Short Term Investments 28,201.0818,394.3218,394.3221,447.3422,089.6537,706.7538,361.9632,950.3433,932.4832,483.1532,427.1729,284.1530,093.5630,057.524,465.0515,288.1913,122.257,207.47
Net Receivables 14,899.73016,482.07013,731.3709,586.53012,011.86012,097.02010,543.506,709.716,740.226,017.850
Inventory 15,770.31016,552.37020,843.48019,453015,597.35011,856.67014,605.22012,751.6810,089.367,562.790
Other Current Assets 5,170.3303,818.6103,690.9702,011.3802,531.0401,674.7602,365.1701,613.581,386.341,609.270
Total Current Assets 64,041.4518,394.3256,451.5221,447.3459,713.1637,706.7569,008.0832,950.3463,090.5932,483.1558,520.7929,284.1556,798.0430,057.551,236.4233,699.1728,462.97,207.47
Non-Current Assets:
Property, Plant & Equipment, Net 39,327.88038,301.52034,132.27017,361.03016,787.96017,268.97015,128.13013,244.4212,259.7811,969.020
Goodwill 2,527.5802,422.5904,555.950000000000000
Intangible Assets 1,124.5901,122.1901,540.20116.610122.370125.350128.3300000
Goodwill and Intangible Assets 3,652.1703,544.7806,096.150116.610122.370125.350128.3300000
Long Term Investments 006,559.130-16,101.450-733.6605,25002,0000-26,839.590-19,477.33506.800
Tax Assets 527.090504.370443.760958.88049.890-415.05027,397.900000
Other Non-Current Assets 1,120.35-18,394.321,251.14-21,447.3418,644.49-37,706.751,064.41-32,950.34913.81-32,483.15836.15-29,284.151,363.17-30,057.519,957.31446.9428.47-7,207.47
Total Non-Current Assets 44,627.49-18,394.3250,160.94-21,447.3443,215.22-37,706.7518,767.27-32,950.3423,124.03-32,483.1519,815.42-29,284.1517,177.94-30,057.513,724.413,213.4812,397.49-7,207.47
Total Assets 108,668.940106,612.460102,928.38087,775.35086,214.62078,336.21073,975.98064,960.8246,912.6540,860.390
Liabilities & Equity:
Current Liabilities:
Account Payables 9,976.6608,626.9209,782.4805,873.507,018.6604,628.504,833.5903,963.494,774.982,490.940
Short Term Debt 2,012.102,309.4702,095.907.0907.0902.6102.6102.979.9310.170
Tax Payables 00516.370614.9409.850398.380179.790865.140286.9758.46107.230
Deferred Revenue 1,028.330516.3701,117.670486.080753.020636.5701,558.560286.91,656.02917.950
Other Current Liabilities 2,370.501,677.1201,751.030640.470527.080670.190-79.580529.45-721.2363.940
Total Current Liabilities 15,387.59013,983.63015,362.0207,291.3308,704.2305,820.2507,180.3205,125.286,478.163,590.230
Non-Current Liabilities:
Long Term Debt 1,254.1801,412.1901,474.4037.44038.35044.82045.32046.9849.9449.940
Deferred Revenue Non-Current 318.010346.7901,248.95049.94049.94055.54055.5500000
Deferred Tax Liabilities Non-Current 2,191.7102,201.2301,338.460842.030943.370877.60776.990738.81732.55740.540
Other Non-Current Liabilities 1,637.45-87,238.431,776.980437.460859.36017.330894.93017.34017.33749.88757.870
Total Non-Current Liabilities 5,401.35-87,238.435,390.404,499.270896.80999.050939.750839.650803.12799.82807.810
Total Liabilities 20,788.94-87,238.4319,374.03019,861.2908,188.1309,703.2806,76008,019.9705,928.47,277.984,398.040
Equity:
Preferred Stock 00000015.5900000000000
Common Stock 164.750164.710164.70164.70164.690164.30164.230163.59154.95154.950
Retained Earnings 0067,878.4800060,153.8800052,343.4500040,226.8133,393.0830,257.180
Accumulated Other Comprehensive Income/Loss 087,238.4387,073.7283,067.0982,902.3979,587.22-15.5976,511.3476,346.6571,576.21114.5465,956.0165,791.7859,032.4218,564.68165.48129.0628,619.99
Other Total Stockholders Equity 87,715.25019,292.2900019,284.2300018,953.9200018,401.095,889.945,889.940
Total Shareholders Equity 87,88087,238.4387,238.4383,067.0983,067.0979,587.2279,587.2276,511.3476,511.3471,576.2171,576.2165,956.0165,956.0159,032.4259,032.4239,634.6736,462.3528,619.99
Total Equity 87,88087,238.4387,238.4383,067.0983,067.0979,587.2279,587.2276,511.3476,511.3471,576.2171,576.2165,956.0165,956.0159,032.4259,032.4239,634.6736,462.3528,619.99
Total Liabilities & Shareholders Equity 108,668.9487,238.43106,612.4683,067.09102,928.3879,587.2287,775.3576,511.3486,214.6271,576.2178,336.2165,956.0173,975.9859,032.4264,960.8246,912.6540,860.3928,619.99